The Prostate Health Index (phi) is an adjunctive PSA-based measurement combining total, free, and [−2] proPSA using a mathematical formula and has been shown to outperform PSA and free PSA for identifying clinically significant PCa [70], and a predictor of biopsy reclassification [34, 71]. The gene discussed is KLK3; the disease is posterior cortical atrophy.